HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 9.44
Day range
GBX 9.10 - GBX 9.50
Year range
GBX 2.10 - GBX 12.50
Market cap
101.29M GBP
Avg Volume
2.33M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 14.13M | 40.93% |
Operating expense | 8.36M | -8.62% |
Net income | -4.06M | 30.62% |
Net profit margin | -28.74 | 50.77% |
Earnings per share | — | — |
EBITDA | -1.74M | 59.19% |
Effective tax rate | -4.59% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.62M | 78.13% |
Total assets | 65.22M | 13.46% |
Total liabilities | 80.29M | 36.56% |
Total equity | -15.08M | — |
Shares outstanding | 723.81M | — |
Price to book | -4.72 | — |
Return on assets | -8.16% | — |
Return on capital | -35.35% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.06M | 30.62% |
Cash from operations | -5.82M | -263.12% |
Cash from investing | 467.00K | 169.39% |
Cash from financing | 6.28M | 277.63% |
Net change in cash | 403.50K | 151.24% |
Free cash flow | -2.00M | 44.56% |
About
CEO
Founded
2008
Website
Employees
63
